Promise of extended-release naltrexone is a red herring

Lancet. 2011 Aug 20;378(9792):663; author reply 663-4. doi: 10.1016/S0140-6736(11)61328-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Buprenorphine / administration & dosage
  • Delayed-Action Preparations
  • Humans
  • Injections
  • Methadone / administration & dosage
  • Naltrexone / administration & dosage*
  • Narcotic Antagonists / administration & dosage*
  • Opiate Substitution Treatment
  • Opioid-Related Disorders / rehabilitation*
  • Russia

Substances

  • Delayed-Action Preparations
  • Narcotic Antagonists
  • Buprenorphine
  • Naltrexone
  • Methadone